These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10445812)

  • 1. Expression of a novel Nef epitope on the surface of HIV type 1-infected cells.
    Yamada T; Iwamoto A
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):1001-9. PubMed ID: 10445812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity via humoral immune epitope of Nef protein expressed on cell surface.
    Yamada T; Watanabe N; Nakamura T; Iwamoto A
    J Immunol; 2004 Feb; 172(4):2401-6. PubMed ID: 14764710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing levels of anti-Nef antibody correlate with increasing HIV type 1 viral loads and AIDS disease progression.
    Chen YM; Lin RH; Lee CM; Fu CY; Chen SC; Syu WJ
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):43-50. PubMed ID: 10024051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4+ T cells.
    Otake K; Fujii Y; Nakaya T; Nishino Y; Zhong Q; Fujinaga K; Kameoka M; Ohki K; Ikuta K
    J Immunol; 1994 Dec; 153(12):5826-37. PubMed ID: 7989778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
    Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to HIV-1 nef(p27): prevalence, significance, and relationship to seroconversion.
    Cheingsong-Popov R; Panagiotidi C; Ali M; Bowcock S; Watkins P; Aronstam A; Wassef M; Weber J
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1099-105. PubMed ID: 2265027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation.
    Crotti A; Neri F; Corti D; Ghezzi S; Heltai S; Baur A; Poli G; Santagostino E; Vicenzi E
    J Virol; 2006 Nov; 80(21):10663-74. PubMed ID: 16943296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping of murine monoclonal antibodies against human immunodeficiency virus type 1 Nef.
    Otake K; Fujii Y; Tashiro M; Adachi A; Kitoh J
    Exp Anim; 1997 Jan; 46(1):53-8. PubMed ID: 9027472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-nef antibodies and other predictors of disease progression in HIV-1 seropositive injecting drug users.
    Rezza G; Titti F; Pezzotti P; Sernicola L; Lo Caputo S; Angarano G; Lazzarin A; Sinicco A; Rossi GB; Verani P
    J Biol Regul Homeost Agents; 1992; 6(1):15-20. PubMed ID: 1359736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological study of the nef protein from HIV-1 by polyclonal and monoclonal antibodies.
    Kienzle N; Bröker M; Harthus HP; Enders M; Erfle V; Buck M; Müller-Lantzsch N
    Arch Virol; 1991; 118(1-2):29-41. PubMed ID: 2048974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.
    Wildum S; Schindler M; Münch J; Kirchhoff F
    J Virol; 2006 Aug; 80(16):8047-59. PubMed ID: 16873261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic epitopes of NEF proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV infection.
    Gombert FO; Blecha W; Tähtinen M; Ranki A; Pfeifer S; Tröger W; Braun R; Müller-Lantzsch N; Jung G; Rübsamen-Waigmann H
    Virology; 1990 Jun; 176(2):458-66. PubMed ID: 1693246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
    Azad AA
    Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Nef-specific CD8 T-cell responses and disease progression in HIV-1 subtype B infection.
    Jiao Y; Li TS; Xie J; Han Y; Qiu ZF; Zuo LY; Mourez T; Wang AX
    Chin Med J (Engl); 2006 Oct; 119(19):1609-15. PubMed ID: 17042973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection.
    Brambilla A; Turchetto L; Gatti A; Bovolenta C; Veglia F; Santagostino E; Gringeri A; Clementi M; Poli G; Bagnarelli P; Vicenzi E
    Virology; 1999 Jul; 259(2):349-68. PubMed ID: 10388660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
    Dis Markers; 1990; 8(4):226-7. PubMed ID: 1708319
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.
    Priceputu E; Hanna Z; Hu C; Simard MC; Vincent P; Wildum S; Schindler M; Kirchhoff F; Jolicoeur P
    J Virol; 2007 May; 81(9):4677-93. PubMed ID: 17314161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.